TfRMAb-TNFR-treated mice also had a greater number of larger Aβ deposits (> 500 μm2) compared with saline-treated 3xTg-AD mice which had a greater number of smaller Aβ deposits (< 500 μm2) (Fig. 4H). This evidence concerns the gene TNFRSF1A and Alzheimer disease.